Are you Dr. Goldsmith?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 63 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Beth Israel Deaconess Med Ctr
330 Brookline Ave., Pathology
Boston, MA 02215Phone+1 617-667-2586
Summary
- Dr. Jeffrey Goldsmith, MD is a board certified pathologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and Pennsylvania. He is affiliated with Beth Israel Deaconess Medical Center, Boston Children's Hospital, and Brigham and Women's Hospital.
Education & Training
University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1996 - 2002
Wayne State University School of MedicineClass of 1996
Certifications & Licensure
MA State Medical License 2002 - 2026
PA State Medical License 1997 - 2002- American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- 67 citationsTTR (Transthyretin) Stabilizers Are Associated With Improved Survival in Patients With TTR Cardiac AmyloidosisHannah Rosenblum, Adam Castano, Julissa Alvarez, Jeff Goldsmith, Stephen Helmke
Circulation. Heart Failure. 2018-04-01 - 13 citationsC. difficile intoxicates neurons and pericytes to drive neurogenic inflammation.John Manion, Melissa A Musser, Gavin A Kuziel, Min Liu, Amy Shepherd
Nature. 2023-10-01 - 131 citationsPrevalence and Prognostic Significance of Low QRS Voltage Among the Three Main Types of Cardiac AmyloidosisNicole B. Cyrille, Jeff Goldsmith, Julissa Alvarez, Mathew S. Maurer
The American Journal of Cardiology. 2014-10-01
Press Mentions
CAP Opens Updated Draft Guideline for Public CommentAugust 4th, 2021
Written Surveys Prove Best for Judging if Lab Practice Guidelines Are WorkingJune 28th, 2019- CAP Updates Validation of Immunohistochemical Assays Testing Guideline for Precise Results, Improved Patient CareFebruary 24th, 2024
